Highbridge Capital Management’s Innophos Holdings, Inc. IPHS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-5,386
Closed -$265K 2128
2017
Q3
$265K Buy
+5,386
New +$243K ﹤0.01% 1268
2017
Q2
Sell
-12,642
Closed -$682K 1782
2017
Q1
$682K Buy
+12,642
New +$652K 0.01% 769
2016
Q4
Sell
-26,965
Closed -$1.05M 1738
2016
Q3
$1.05M Buy
+26,965
New +$1.11M 0.02% 553
2016
Q2
Sell
-14,337
Closed -$444K 1907
2016
Q1
$444K Sell
14,337
-14,087
-50% -$388K 0.01% 1027
2015
Q4
$823K Buy
+28,424
New +$1M 0.01% 822
2015
Q1
Sell
-9,499
Closed -$555K 1682
2014
Q4
$555K Buy
+9,499
New +$533K 0.01% 793
2014
Q1
Sell
-6,546
Closed -$318K 1324
2013
Q4
$318K Buy
+6,546
New +$327K ﹤0.01% 819

Other funds holding IPHS

Highbridge Capital Management's IPHS Position: Q4 2017 in Review

Highbridge Capital Management sold out of Innophos Holdings, Inc. (IPHS) in Q4 2017, closing a stake of 5,386 shares — an estimated $265K sold.

Highbridge Capital Management first reported a position in IPHS in Q4 2013 and held it in 7 quarters. The position peaked at $1.05M in Q3 2016. 180 funds tracked by Wall St. Rank hold IPHS as of Q4 2017.

  • Highbridge Capital Management reported no remaining Innophos Holdings, Inc. position as of Q4 2017 after selling out during the quarter.
  • Highbridge Capital Management sold 5,386 Innophos Holdings, Inc. shares in Q4 2017, an estimated $265K.
  • Highbridge Capital Management first reported a position in Innophos Holdings, Inc. in Q4 2013 and held it in 7 quarters.
  • Highbridge Capital Management's Innophos Holdings, Inc. position peaked at $1.05M in Q3 2016.
  • 180 funds tracked by Wall St. Rank held Innophos Holdings, Inc. as of Q4 2017.

Based on Highbridge Capital Management's 13F filing for Q4 2017, filed 14 Feb 2018.